| |
original article |
Date |
Title |
Authors Max. 6 Authors |
| 1 |
[GO] |
2026―Jun―17 |
How mutation-driven predisposition shapes the accelerated adaptive trajectory of SARS-CoV-2: the role of NSP4 T492I |
Yan Li, Jiawei Zeng, Chen Jiang, Liang Leng, Zhenglin Zhu |
| 2 |
[GO] |
2026―Jun―05 |
Quantitative analysis of Epstein-Barr virus in upper respiratory tract samples of hospitalized patients with COVID-19 |
Sara Sheikh Veisi, Hossein Ghorbani, Sara Babazadeh, Talieh Mostaghimi, Mohammad Ranaee, Hoda Shirafkan, Mana Baziboroun, Farzin Sadeghi |
| 3 |
[GO] |
2026―May―19 |
Five years of SARS-CoV-2 evolution: variants, mechanisms, and public health challenges |
Gonzalo Emiliano Aranda-Abreu, Fausto Rojas-Durán, María Elena Hernández-Aguilar, Deissy Herrera-Covarrubias, Luis Roberto Tlapa-Monge, César Antonio Pérez-Estudillo, Albert Cortés-Borra, Sonia Lilia Mestizo-Gutiérrez |
| 4 |
[GO] |
2026―May―16 |
The impact of COVID-19 vaccines on reinfection in Vietnam and Indonesia: the role of vaccine technology and dosage |
An Hoai Duong, Giang Thi Nguyen, Hien Thi Vu, Lam Xuan Duong, Hue Thi Pham, Ernoiz Antriyandarti |
| 5 |
[GO] |
2026―May―07 |
Exosome-based strategies for COVID-19: a comprehensive review of diagnostic and therapeutic applications |
Chunyan Tang, Wen Gao, Yixian You, Xiong Pei, Qingmin Zeng, Wei Jiang, Dongbo Wu, Bangqiong Weng, Taoyou Zhou |
| 6 |
[GO] |
2026―Mar―06 |
Higher rate of Epstein-Barr virus co-infection with SARS-CoV-2 compared to adenovirus, Influenza A, and B viruses in Northeast Iran |
Mina Norozi, Sammaneh Pirjane, Sadegh Ali Azimi, Arash Letafati, Zahra Taghiabadi, Mohsen Ebrahimi, Fatemeh Mehravar, Alijan Tabarraei, Hadi Razavi Nikoo |
| 7 |
[GO] |
2026―Mar―06 |
Neurological implications of cytokine storm and oxidative stress in COVID-19: pathophysiological insights and clinical perspectives |
Hadi Rezaei Matanaq, Alireza Mohammadzadeh, Elham Sheykhsaran, Amin Abbasi, Abolfazl Jafari-Sales, Reyhaneh Rasizadeh, Hossein Bannazadeh Baghi |
| 8 |
[GO] |
2026―Feb―23 |
Fat-soluble vitamin A, D and E in HBV and SARS-CoV-2 infections: a narrative review |
Sirio Fiorino, Wandong Hong, Dario de Biase, Federico Lari, Stefano Sbrignadello, Claudio Giuseppe Gallo, Alfonso Grottesi, Maddalena Zippi |
| 9 |
[GO] |
2026―Feb―11 |
Epidemiological and clinical profile of respiratory viral infections in 2021: integrated surveillance during the COVID-19 pandemic |
Katia Ozanic, Aripuanã Sakurada Aranha Watanabe, Antonio Charlys da Costa, Vanessa Galdeno Freitas, Eva Maria de Assis de Carvalho, Vanessa Dias Cordeiro, Vania Lucia da Silva, Alessandra Barbosa Ferreira Machado, Claudio Galuppo Diniz |
| 10 |
[GO] |
2026―Feb―07 |
Reactivation of Human herpesviruses (HHVs) following SARS-CoV-2 infection and vaccination: a systematic review of clinical studies |
Seyedeh Shahed Shoarishoar, Maryam Esmaeilpour, Maziar Naderi |
| 11 |
[GO] |
2025―Dec―30 |
Neurological complications and pathophysiological pathways of the novel coronavirus SARS-CoV-2: a systematic review |
Maziar Naderi, Zahra Ghiyasi, Payam Farjami, Danyal Yarahmadi, Sheida Bashiri Goodarzi, Mohammad Aboutalebi, Neda Parnianfard |
| 12 |
[GO] |
2025―Dec―24 |
A pseudovirus system for SARS-CoV-2 for screening antiviral agents and phytochemical extracts |
Jacqueline Tze Chin Wong, Cahyo Budiman, Peik Lin Teoh |
| 13 |
[GO] |
2025―Dec―23 |
Prevalence and predictors of Post-Acute Sequelae of COVID-19 two years after SARS-CoV-2 infection: the role of vaccination, hospitalization, reinfection, and peripheral blood immunological profile in an ambidirectional cohort study |
Hawbash M. Rahim, Gasha S. Ahmed, Salih A. Hama |
| 14 |
[GO] |
2025―Dec―09 |
Decreased production of antiviral factors in patients infected with SARS-CoV-2 due to reduced TLR7 expression |
Julia Cataldo Lima, Emily Araujo de Oliveira, Luana de Mendonça Oliveira, Sarah Cristina Gozzi-Silva, Anna Cláudia Calvielli Castelo Branco, Ricardo Wesley Alberca Custódio, Iara Grigoletto Fernandes, Alberto José da Silva Duarte, Cyro Alves de Brito, Maria Notomi Sato, Nátalli Zanete Pereira |
| 15 |
[GO] |
2025―Dec―03 |
Epidemiological analysis of SARS-CoV-2 variants in Saudi Arabia |
Mohamed A. Farrag, Reem M. Aljowaie, Rasha M. Alzayed, Ibrahim M. Aziz, Sondos A. Alhajouj, Khalid Abdullah N. Alaboudi, Abdulaziz Abdullah Almosa, Mahmoud Bayoumi, Fahad N. Almajhdi |
| 16 |
[GO] |
2025―Dec―01 |
New antiviral peptides inhibit
in vitro
infection of SARS-CoV-2 |
Camila Innocente-Alves, Laura Rascovetzki Saciloto-de-Oliveira, Raul Izidoro Carneiro, Crisciele Fontana, Isabella Alvim Guedes, Viviane Guimarães Gomes, Rafael Lopes da Rosa, Jorge Almeida Guimarães, Lucélia Santi, Alexandre José Macedo, Amílcar Tanuri, Hugo Verli, Walter Orlando Beys-da-Silva |
| 17 |
[GO] |
2025―Nov―26 |
Reframing sanggenon G as an artifactual inhibitor of SARS-CoV-2 main protease via integrated biochemical experiments |
Chunlei Xu, Jiankai Ye, Yunyu Chen |
| 18 |
[GO] |
2025―Oct―09 |
Pandemic cholera: a global pathogen shaped by bacteriophages |
Micah J. Ferrell, Christopher M. Waters |
| 19 |
[GO] |
2025―Aug―07 |
Human coronavirus OC43 in Saudi Arabia: molecular epidemiology and prevalence in hospitalized children during 2022-24 |
Reem M. Aljowaie, Mohamed A. Farrag, Ibrahim M. Aziz, Noorah A. Alkubaisi, Rasha M. Alzayed, Sondos A. Alhajouj, Noura S. Aldosari, Abdulkarim F. Alhetheel, Fahad N. Almajhdi |
| 20 |
[GO] |
2025―Jun―27 |
Modulatory effects of
Eucalyptus
spp. essential oils and eucalyptol on cytokines and antiviral activity against SARS-CoV-2 |
Fabiana Barcelos Furtado, Marina Raquel Bento de Camargo, Luidy Carlos de Souza Santos Quispe, William de Souza Li, Agatha Mayume Silva Kubo, Maria Letícia de Oliveira Lyra, Leonardo Nazário de Moraes, Aline Márcia Marques Braz, Edivaldo Domingues Velini, Marjorie de Assis Golim, Marcelo Viana De Moraes, Guilherme Targino Valente, Carlos Magno Castelo Branco Fortaleza, Rejane Maria Tommasini Grotto |
| 21 |
[GO] |
2025―Apr―11 |
Review of the relationship between growth hormone and SARS-CoV-2 infection |
Yousef Rasmi, Kevser Kübra Kırboğa, Neda Roshanravan, Burcu Tekin, Ladan Jalali, Farid Ghazizadeh |
| 22 |
[GO] |
2025―Mar―28 |
The reactivation of the various types of viruses following COVID-19 infection: a systematic review |
Maziar Naderi, Mohieddin Naderi, Mahboob Keramati Jamal, Vida Past, Arezoo Esmaeili, Aynaz Khabazian, Somayeh Hashemi Ali Abadi, Golbarg Saremi, Shima Asghari, Shadi Moghimi, Neda Parnianfard, Mina Parnianfard |
| 23 |
[GO] |
2025―Mar―21 |
Neurofilament light chain as a biomarker for neurodegenerative changes in COVID-19 and clinical implications |
Yousef Rasmi, Yeganeh Farnamian, Marijana Markovic Boras, Nihal Inandiklioglu, Charles Adolfu Shirima, Ladan Jalali |
| 24 |
[GO] |
2025―Feb―24 |
Development and evaluation of MMIRA-CRISPR/Cas13a-MBQD assay for the detection of influenza A/B viruses and SARS-CoV-2 |
Ning Yang, Jun-Yan Ma, Qiao Qiao, Xiao-Juan Zhu, Tao Wu, Kang-Chen Zhao, Ying Chi, Ge Hu, Zi-Yang Hao, Lun-Biao Cui, Yi-Yue Ge |
| 25 |
[GO] |
2025―Feb―11 |
Spironolactone as an adjuvant treatment for COVID-19: a systematic review and meta-analysis |
Arman Shafiee, Mohammad Javad Amini, Mohammad Ali Rafiei, Amirhossein Akhondi, Kyana Jafarabady, Ghazale Molaverdi, Sayed-Hamidreza Mozhgani |
| 26 |
[GO] |
2025―Jan―09 |
COVID-19 treatment that contains ritonavir may interact with other drugs: a plain language summary |
Kaylen Brzozowski, Amy Puenpatom, Ebuwa Igho-Osagie, Marissa Grifasi Williams |
| 27 |
[GO] |
2024―Dec―16 |
Implication of iron overload in COVID-19 pathogenesis and long COVID: a mechanistic review |
Bijita Bhowmick, Anirban Roy, Avipsha Sarkar, Tanusree Ghorai, Debadatta Nayak, Satadal Das |
| 28 |
[GO] |
2024―Nov―16 |
Exploring plasma expression levels of miR-200c-3p, miR-150, and miR-155 in SARS-CoV-2 positive and negative subjects |
Ehsan Kakavandi, Somayeh Shatizadeh Malekshahi, Kaveh Sadeghi, Mohammad Shayestehpour, Abbas Rahimi Foroushani, Talat Mokhtari-Azad, Nazanin-Zahra Shafiei-Jandaghi, Jila Yavarian |
| 29 |
[GO] |
2024―Sep―25 |
Transitioning from Crisis to Control: Reviewing Antiviral Agents Targeting Pandemic Viruses |
Deepali Nahar, Sayali Ayare, Meena Kanyalkar |
| 30 |
[GO] |
2024―Aug―12 |
The treatment of COVID-19: lessons learned and future directions |
Michael A Cenname, Matthew W McCarthy |
| 31 |
[GO] |
2024―Jun―17 |
Genomic epidemiology and phylogeographic dynamics of SARS-CoV-2 during the sixth wave and post-sixth wave in Pakistan |
Zunera Jamal, Syed Adnan Haider, Muhammad Ammar, Zaira Rehman, Afreenish Amir, Aamer Ikram, Muhammad Salman, Massab Umair |
| 32 |
[GO] |
2024―Jun―17 |
Remarkable proliferative ability of the Omicron variant in the nasal cavity compared to other SARS-CoV-2 variants |
Hirokazu Yamagishi, Daisuke Tamura, Yuji Morisawa, Takashi Mato, Shin Nunomiya, Toshihiro Tajima, Hitoshi Osaka |
| 33 |
[GO] |
2024―Jun―05 |
Resistance analysis in the phase III COMET-TAIL study: treatment of COVID-19 with intramuscular or intravenous sotrovimab |
Maria L Agostini, Gretja Schnell, Julia di Iulio, Anita Kohli, Adrienne E Shapiro, Elias H Sarkis, Naomi Givens, Amanda Peppercorn, Andrew Skingsley, Leah A Gaffney, Melissa Aldinger, Christy M Hebner, Andrea L Cathcart |
| 34 |
[GO] |
2024―May―18 |
Coping with the Third wave of the COVID-19 Pandemic in Africa: Implications for an Improved Outbreak Response |
Olayinka Stephen Ilesanmi, Francesco Chirico, Aanuoluwapo Adeyimika Afolabi, Gabriella Nucera |
| 35 |
[GO] |
2024―Apr―12 |
RNAi-mediated inhibition of SARS-CoV-2: applications and challenges |
Debosmita Sanyal, Binay Chaubey |
| 36 |
[GO] |
2024―Mar―26 |
Exploration of the cross-immunity between SARS-CoV and SARS-CoV-2 in mice |
Shuhui Wang, Li Ren, Ying Liu, Xiuli Shen, Yanling Hao, Yiming Shao |
| 37 |
[GO] |
2024―Mar―18 |
Direct virus capture assay for label-free detection of SARS-CoV-2 virions using laser microscopy |
Alessandro Pennesi, Guglielmo Ferrari, Federica Giardina, Sara Piselli, Roberto Lo Savio, Adolfo Carloni, Stefania Paolucci, Fausto Baldanti |
| 38 |
[GO] |
2024―Feb―26 |
Real-life use of high-dose anakinra in patients with COVID-19 treated with remdesivir |
Roberta Monardo, Andrea Mastrangelo, Laura Galli, Alessandro Tomelleri, Vincenzo Spagnuolo, Chiara Oltolini, Giacomo Ponta, Corrado Campochiaro, Giulio Cavalli, Lorenzo Dagna, Fabio Ciceri, Paola Cinque, Paolo Scarpellini, Antonella Castagna, Marco Ripa |
| 39 |
[GO] |
2024―Feb―09 |
Developing a risk prediction model for COVID-19 infection in heart transplant recipients using artificial intelligence |
Shriya Sharma, Nora Menon, Jose Ruiz, Caitlyn Luce, Lisa Brumble, Anirban Bhattacharya, Rohan Goswami |
| 40 |
[GO] |
2024―Feb―05 |
Preliminary application of a coronavirus pseudovirus system |
Xiaoli Tao, Tengfei Li, Baojun He, Wei Zhao, Siman Hu, Zhuping Ma, Lvyin Sun, Runlin Li, Like Luo, Yonggang Li |
| 41 |
[GO] |
2023―Dec―21 |
Resistance analysis following sotrovimab treatment in participants with COVID-19 during the phase III COMET-ICE study |
Sambhavi Subramanian, Gretja Schnell, Julia di Iulio, Anil K Gupta, Adrienne E Shapiro, Elias H Sarkis, Amanda Lopuski, Amanda Peppercorn, Melissa Aldinger, Christy M Hebner, Andrea L Cathcart |
| 42 |
[GO] |
2023―Dec―19 |
Effect of the COVID-19 pandemic on the reporting of Crimean-Congo hemorrhagic fever |
Mohammad Hassan Pouriayevali, Ehsan Mostafavi, Mehdi Fazlalipour, Tahmineh Jalali, Sahar Khakifirouz, Seyed Dawood Mosavi-Nasab, Mostafa Salehi-Vaziri |
| 43 |
[GO] |
2023―Nov―07 |
Validation of a risk prediction model for COVID-19: the PERIL prospective cohort study |
Shahd A Mohammedain, Saif Badran, AbdelNaser Y Elzouki, Halla Salim, Ayesha Chalaby, MYA Siddiqui, Yehia Y Hussein, Hanan Abdul Rahim, Lukman Thalib, Mohammed Fasihul Alam, Daoud Al-Badriyeh, Sumaya Al-Maadeed, Suhail AR Doi |
| 44 |
[GO] |
2023―Nov―07 |
Antiviral attributes of bee venom as a possible therapeutic approach against SARS-CoV-2 infection |
Soumik Goswami, Jayita Pal Chowdhury |
| 45 |
[GO] |
2023―Nov―01 |
Oral bemnifosbuvir (AT-527) vs placebo in patients with mild-to-moderate COVID-19 in an outpatient setting (MORNINGSKY) |
Arantxa Horga, Rebecca Saenz, Gürdal Yilmaz, Abraham Simón-Campos, Keith Pietropaolo, William J Stubbings, Neil Collinson, Laura Ishak, Barbara Zrinscak, Bruce Belanger, Catherine Granier, Kai Lin, Aeron C Hurt, Xiao-Jian Zhou, Steffen Wildum, Janet Hammond |
| 46 |
[GO] |
2023―Oct―26 |
In silico identification of deep-sea fungal alkaloids as potential inhibitors of SARS-CoV-2, Delta and Omicron spikes |
Abdullah R Alanzi, Mohammad K Parvez, Mohammed S Al-Dosari |
| 47 |
[GO] |
2023―Oct―18 |
Genotoxicity: a neglected but potentially critical aspect of adenoviral COVID-19 vaccines |
Alireza Mardomi, Tahoora Mousavi, Farahnoosh Farnood, Hamid Tayebi Khosroshahi |
| 48 |
[GO] |
2023―Sep―19 |
‘The end’ - or is it? Emergence of SARS-CoV-2 EG.5 and BA.2.86 subvariants |
Farid Rahimi, Mohammad Darvishi, Amin Talebi Bezmin Abadi |
| 49 |
[GO] |
2023―Sep―11 |
Targeting host calcium channels and viroporins: a promising strategy for SARS-CoV-2 therapy |
Mona Fani, Maryam Moossavi, Hasan Bakhshi, Abozar Nasiri Jahrodi, Mohammad Reza Khazdair, Amir Hossein Zardast, Shokouh Ghafari |
| 50 |
[GO] |
2023―Jul―28 |
Plain Language Summary of a Clinical Trial Evaluating mRNA-1273, Moderna's mRNA-Based COVID-19 Vaccine, in Children 6 Through 11 Years of Age |
CB Creech, E Anderson, V Berthaud, I Yildirim, AM Atz, I Melendez Baez, D Finkelstein, P Pickrell, J Kirstein, C Yut, R Blair, RA Clifford, M Dunn, JD Campbell, DC Montefiori, JE Tomassini, X Zhao, W Deng, H Zhou, D Ramirez Schrempp, K Hautzinger, B Girard, K Slobod, R McPhee, R Pajon, R Das, JM Miller, S Schnyder Ghamloush |
| 51 |
[GO] |
2023―Jul―13 |
Expression of TRIM56 gene in SARS-CoV-2 variants and its relationship with progression of COVID-19 |
Rezvan Tavakoli, Pooneh Rahimi, Mojtaba Hamidi-Fard, Sana Eybpoosh, Delaram Doroud, Iraj Ahmadi, Enayat Anvari, Mohammadreza Aghasadeghi, Abolfazl Fateh |
| 52 |
[GO] |
2023―Jun―24 |
Design and generation of mRNAs encoding conserved regions of SARS-CoV-2 ORF1ab for T cell-mediated immune activation |
Cao Minh Nguyen, Bac An Luong, Thu Thuy Thi Tran, Hoai Nghia Nguyen, Le Son Tran |
| 53 |
[GO] |
2023―Jun―23 |
Phase II study of bemnifosbuvir in high-risk participants in a hospital setting with moderate COVID-19 |
Arantxa Horga, Daniel R. Kuritzkes, John J. Kowalczyk, Keith Pietropaolo, Bruce Belanger, Kai Lin, Kristen Perkins, Janet Hammond |
| 54 |
[GO] |
2023―Jun―16 |
COVID-19 post vaccination neuronal adverse events: probable mechanisms and treatment possibilities |
Abdul Mannan Baig, Joachim Gerlach, Prakash Salunke, Rachel Jessey, Robin Rose |
| 55 |
[GO] |
2023―Jun―16 |
Effects of COVID-19 and vaccination on the human immune system: cases of lymphopenia and autoimmunity |
Joachim Gerlach, Abdul Mannan Baig |
| 56 |
[GO] |
2023―Jun―07 |
Plant protease inhibitors against SARS-CoV-2 main protease: an in silico approach |
Adrianne M Lima, Adson A de Souza, Jackson L Amaral, Valder N Freire, Pedro F N Souza, Hermógenes D de Oliveira |
| 57 |
[GO] |
2023―Jun―01 |
CpG 684: an effective adjuvant for the inactivated COVID-19 vaccine in mice |
Jiandong Liu, Tianle Cang, Congli Jiang, Kelei Li, Siyuan Liu, Haixin Wang, Meirong Wang, Yan Chen, Yan Shao, Jiankai Liu |
| 58 |
[GO] |
2023―Jun―01 |
Structure-based virtual identification of natural inhibitors of SARS-CoV-2 and its Delta and Omicron variant proteins |
Abdullah R Alanzi, Mohammad K Parvez, Mohammed S Al-Dosari |
| 59 |
[GO] |
2023―May―22 |
In silico assessment of diterpenes as potential inhibitors of SARS-COV-2 main protease |
Yousef A Abdelrady, Naeem Mahmood Ashraf, Arslan Hamid, Hayam S Thabet, Asmaa M Sayed, Shimaa H Salem, Emad HM Hassanein, Ahmed M Sayed |
| 60 |
[GO] |
2023―May―22 |
Identification of host factors that bind to the 5′ end of the MERS-CoV RNA genome |
Bader Y Alhatlani, Waleed Aljabr, Fatimah S Alhamlan, Ahmad Almatroudi, Mohd Azam, Mansour Alsaleem, Khaled S Allemailem |
| 61 |
[GO] |
2023―Apr―17 |
Efficiency rating of SG Diagnostics COVID-19 antigen rapid test kit |
Francesco Chirico, Murat Yıldırım, Tomasz Dzieciatkowski, Marek Dabrowski, Marek Malysz, Marcin Madziala, Milosz Jaroslaw Jaguszewski, Karol Bielski, Gabriella Nucera, Krzysztof J Filipiak, Lukasz Szarpak |
| 62 |
[GO] |
2023―Apr―11 |
DPP-4 Inhibitors as a savior for COVID-19 patients with diabetes |
Snehasish Nag, Samanwita Mandal, Oindrila Mukherjee, Suprabhat Mukherjee, Rakesh Kundu |
| 63 |
[GO] |
2023―Apr―11 |
In silico analysis of ACE2 from different animal species provides new insights into SARS-CoV-2 species spillover |
Felipe Pantoja Mesquita, Pedro Filho Noronha Souza, Dyane Rocha Aragão, Expedito Maia Diógenes, Emerson Lucena da Silva, Jackson Lima Amaral, Valder Nogueira Freire, Débora de Souza Collares Maia Castelo-Branco, Raquel Carvalho Montenegro |
| 64 |
[GO] |
2023―Apr―06 |
The impact of mutation sets in receptor-binding domain of SARS-CoV-2 variants on the stability of RBD-ACE2 complex |
Mykyta Peka, Viktor Balatsky |
| 65 |
[GO] |
2023―Apr―04 |
Evidence-based policies in public health to address COVID-19 vaccine hesitancy |
Francesco Chirico, Jaime A Teixeira da Silva |
| 66 |
[GO] |
2023―Mar―14 |
Natural killer cells in COVID-19: from infection, to vaccination and therapy |
Alireza Zafarani, Mohammad Hossein Razizadeh, Salar Pashangzadeh, Mohammad Reza Amirzargar, Mahsa Taghavi-Farahabadi, Mohammad Mahmoudi |
| 67 |
[GO] |
2023―Mar―09 |
A twisting tale of misinformation: should ivermectin be approved as a treatment for COVID-19 disease? |
Arman Shafiee, Mohammad Mobin Teymouri Athar, Sayed-Hamidreza Mozhgani |
| 68 |
[GO] |
2023―Mar―06 |
Two sides of the same coin: the N-terminal and the receptor binding domains of SARS-CoV-2 Spike |
Massimo Ciccozzi, Stefano Pascarella |
| 69 |
[GO] |
2023―Feb―20 |
HLA and red blood cell antigen genotyping in SARS-CoV-2 convalescent plasma donors |
William Lemieux, Josée Perreault, Gabriel André Leiva-Torres, Nadia Baillargeon, Jessica Constanzo Yanez, Marie-Claire Chevrier, Lucie Richard, Antoine Lewin, Patrick Trépanier |
| 70 |
[GO] |
2023―Feb―03 |
SARS-CoV-2 RNA-dependent RNA polymerase as a target for high-throughput drug screening |
Jiahui Wu, Zhiqiang Chen, Xue Han, Qiaoqiao Chen, Yintao Wang, Tingting Feng |
| 71 |
[GO] |
2023―Jan―27 |
Is the emergence of the zoonotic Langya virus amidst COVID-19 and monkeypox a cause for concern? |
Chandan Kumar Thakur, Jog Bahadur Adhikari, Nitin Gupta, Prakash Ghimire, Meghnath Dhimal |
| 72 |
[GO] |
2023―Jan―19 |
Update on the treatment of multisystem inflammatory syndrome in children associated with COVID-19 |
Fangyuan Long, Shiheng Zhu, Zeguang Wang, Shungeng Zhang, Jinlong He, Xinbin Ge, Jun Ning |
| 73 |
[GO] |
2023―Jan―16 |
Plain language summary of Pfizer-BioNTech BNT162b2 vaccine protection against COVID-19 and its safety in participants 12- to 15-years-old |
Robert W Frenck, Nicola P Klein, Nicholas Kitchin, Alejandra Gurtman, Judith Absalon, Stephen Lockhart, John L Perez, Emmanuel B Walter, Shelly Senders, Ruth Bailey, Kena A Swanson, Hua Ma, Xia Xu, Kenneth Koury, Warren V Kalina, David Cooper, Timothy Jennings, Donald M Brandon, Stephen J Thomas, Özlem Türeci, Dina B Tresnan, Susan Mather, Philip R Dormitzer, Uğur Şahin, Kathrin U Jansen, William C Gruber |
| 74 |
[GO] |
2023―Jan―10 |
Diagnosing COVID-19: diagnostic importance of detecting E gene of the SARS-CoV-2 genome |
Iva Barjaktarović, Jelena Stojčević Maletić, Nataša Vučinić, Aleksandra Milutinović, Maja Grujičić, Velibor Čabarkapa |
| 75 |
[GO] |
2023―Jan―09 |
The prevalence of deep vein thrombosis and associated risk factors among patients with COVID-19 in the North of Iran |
Maryam Yaseri, Seyyedeh Sahereh Mortazavi Khatibani, Elahe Ghorbani Totkaboni, Haniyeh Sadat Fayazi |
| 76 |
[GO] |
2022―Nov―25 |
Plain language summary of Pfizer-BioNTech BNT162b2 COVID-19 vaccine safety in participants 16 years or older and protection against COVID-19 in participants 12 years or older |
Stephen J Thomas, Edson D Moreira, Nicholas Kitchin, Judith Absalon, Alejandra Gurtman, Stephen Lockhart, John L Perez, Gonzalo Pérez Marc, Fernando P Polack, Cristiano Zerbini, Ruth Bailey, Kena A Swanson, Xia Xu, Satrajit Roychoudhury, Kenneth Koury, Salim Bouguermouh, Warren V Kalina, David Cooper, Robert W Frenck, Laura L Hammitt, Özlem Türeci, Haylene Nell, Axel Schaefer, Serhat Ünal, Qi Yang, Paul Liberator, Dina B Tresnan, Susan Mather, Philip R Dormitzer, Uğur Şahin, William C Gruber, Kathrin U Jansen |
| 77 |
[GO] |
2022―Oct―22 |
Variation analysis of SARS-CoV-2 complete sequences from Iran |
Jale Moradi, Parnia Moradi, Amir H Alvandi, Ramin Abiri, Mohsen Moghoofei |
| 78 |
[GO] |
2022―Oct―17 |
Blood types (ABO/Rhesus) and SARS-CoV-2 infection: a retrospective, cross-sectional study in 2828 healthcare workers |
Betul Copur, Serkan Surme, Ugurcan Sayili, Gulsah Tuncer, Melike Nur Ozcelik, Hulya Yilmaz-Ak, Muge Topal, Sumeyye Ustun-Al, Filiz Pehlivanoglu, Gonul Sengoz |
| 79 |
[GO] |
2022―Sep―26 |
Reinfection and reactivation of SARS-CoV-2 |
Razieh Dowran, Amirmasoud Rayati Damavandi, Talat Mokhtari Azad |
| 80 |
[GO] |
2022―Sep―26 |
Rapid antigen test for SARS-CoV-2: results of validation and use in real life |
Irena Grmek Kosnik, Urska Dermota, Andrej Golle, Tjasa Zohar Cretnik |
| 81 |
[GO] |
2022―Sep―23 |
Similarity between cutaneous reactions due to SARS-CoV-2 and its vaccinations |
Ömer Kutlu, Selami Aykut Temiz |
| 82 |
[GO] |
2022―Sep―16 |
Relevance of cycle threshold values in mass screening by reverse-transcription-PCR during COVID-19 pandemic in Belgium: a decision-making support? |
Patrice Dufour, Henry Paridaens, Jean-Marc Senterre, Jean-Marc Minon |
| 83 |
[GO] |
2022―Sep―14 |
A plain language summary of the Janssen COVID-19 vaccine effectiveness and safety as a single dose and with a booster |
Frank Struyf, Jerald Sadoff, Karin Hardt, Macaya Douoguih |
| 84 |
[GO] |
2022―Aug―31 |
Sudden onset of decreased vision following Delta variant of SARS-CoV-2 infection: a case report |
Akram Sadat Ahmadi, Nazanin Zahra Shafiei-Jandaghi, Kaveh Sadeghi, Mohammadreza Salehi, Talat Mokhtari-Azad, Jila Yavarian |
| 85 |
[GO] |
2022―Aug―08 |
Digging for the discovery of SARS-CoV-2 nsp12 inhibitors: a pharmacophore-based and molecular dynamics simulation study |
Fatemeh Sana Askari, Mohsen Ebrahimi, Jabbar Parhiz, Mina Hassanpour, Alireza Mohebbi, Abbas Mirshafiey |
| 86 |
[GO] |
2022―Aug―02 |
Cholesterol-lowering drugs for high-risk hypercholesterolemia patients with COVID-19 while on Paxlovid™ therapy |
Alpo Vuorio, Petri T Kovanen, Frederick Raal |
| 87 |
[GO] |
2022―Aug―02 |
Structural analysis of spike proteins from SARS-CoV-2 variants of concern highlighting their functional alterations |
Kundan Solanki, Sajjan Rajpoot, Ashutosh Kumar, Kam Y J Zhang, Tomokazu Ohishi, Nik Hirani, Khandu Wadhonkar, Pramod Patidar, Qiuwei Pan, Mirza S Baig |
| 88 |
[GO] |
2022―Jul―22 |
Tripartite communication in COVID-19 infection: SARS-CoV-2 pathogenesis, gut microbiota and ACE2 |
Sara Ahmadi Badi, Shohreh Khatami, Seyed Davar Siadat |
| 89 |
[GO] |
2022―Jul―19 |
A rare case of septic pulmonary embolism in co-existence with infective endocarditis and COVID-19 |
Yusuf Emre Ozdemir, Adile Sevde Demir, Meryem Sahin Ozdemir, Busra Mavi, Can Ozen, Hayat Kumbasar Karaosmanoglu |
| 90 |
[GO] |
2022―Jul―19 |
Nothing in SARS-CoV-2 makes sense except in the light of RNA modification? |
Mingmei Zhao, Chunxiao Li, Yu Dong, Xuekun Wang, Wenqing Jiang, Yaogang Chen |
| 91 |
[GO] |
2022―Jul―01 |
Molecular and antigen tests, and sample types for diagnosis of COVID-19: a review |
Yujia Zhang, Rachael Garner, Sana Salehi, Marianna La Rocca, Dominique Duncan |
| 92 |
[GO] |
2022―Jul―01 |
SARS-CoV-2 and its repercussive effect on reproductive health: recent trends |
Sukanth Kumar Enmozhi, Jerrine Joseph |
| 93 |
[GO] |
2022―Jun―28 |
IGA nephropathy and spinal epidural abscess after COVID-19 infection: a case report |
Burak Göre, Ezgi Coşkun Yenigün, Şimal Köksal Cevher, Emre Çankaya, Numan Aydın, Fatih Dede |
| 94 |
[GO] |
2022―Jun―16 |
A comprehensive account of SARS-CoV-2 genome structure, incurred mutations, lineages and COVID-19 vaccination program |
Vijay Rani Rajpal, Shashi Sharma, Deepmala Sehgal, Apekshita Singh, Avinash Kumar, Samantha Vaishnavi, Mugdha Tiwari, Hemal Bhalla, Shailendra Goel, Soom Nath Raina |
| 95 |
[GO] |
2022―Jun―15 |
Clinical course of idiopathic inflammatory myopathies in COVID-19 pandemic: a single-center experience |
Hakan Apaydin, Abdulsamet Erden, Serdar C Güven, Berkan Armağan, Özlem Karakaş, Bahar Özdemir, Bünyamin Polat, Mehmet Akif Eksin, Ahmet Omma, Orhan Kucuksahin |
| 96 |
[GO] |
2022―Jun―08 |
Detection of SARS-CoV-2 N501Y mutation among SARS-CoV-2 variants of concern circulating in Northern Cyprus |
Gulten Tuncel, Mahmut Cerkez Ergoren, Buket Baddal, Pinar Tulay, Cenk Serhan Ozverel, Emrah Guler, Huseyin Kaya Suer, Murat Sayan, Tamer Sanlidag |
| 97 |
[GO] |
2022―Jun―03 |
Mapping of SARS-CoV-2 spike protein evolution during first and second waves of COVID-19 infections in India |
Vijay Rani Rajpal, Shashi Sharma, Avinash Kumar, Samantha Vaishnavi, Apekshita Singh, Deepmala Sehgal, Mughdha Tiwari, Shailendra Goel, Soom Nath Raina |
| 98 |
[GO] |
2022―Jun―03 |
Efficacy and safety of corticosteroid regimens for the treatment of hospitalized COVID-19 patients: a meta-analysis |
Fangwen Zhou, Jiawen Deng, Kiyan Heybati, Qi Kang Zuo, Saif Ali, Wenteng Hou, Chi Yi Wong, Harikrishnaa Ba Ramaraju, Oswin Chang, Thanansayan Dhivagaran, Zachary Silver |
| 99 |
[GO] |
2022―May―09 |
Evaluation of SARS-CoV-2 genome detection by real-time PCR assay using pooled specimens |
Forough Tavakoli, Jila Yavarian, Nazanin Zahra Shafiei Jandaghi, Kaveh Sadeghi, Nastaran Ghavami, Vahid Salimi, Talat Mokhtari-Azad |
| 100 |
[GO] |
2022―Apr―26 |
Neutralization heterogeneity of circulating SARS-CoV-2 variants to sera elicited by a vaccinee or convalescent |
Meng Zhang, Yixin Gong, Shunchang Jiao |
| 101 |
[GO] |
2022―Apr―19 |
Need for more robust research on the effectiveness of masks in preventing COVID-19 transmission |
Jingjing Nie, Linna Kang, Yaya Pian, Jihong Hu |
| 102 |
[GO] |
2022―Apr―19 |
Toll-like receptor 4 in COVID-19: friend or foe? |
Suprabhat Mukherjee |
| 103 |
[GO] |
2022―Apr―11 |
Evaluation of rapid antigen detection kits for detection of SARS-CoV-2 B.1.617.2 virus |
Gannon CK Mak, Stephen SY Lau, Kitty KY Wong, Nancy LS Chow, Chi-Shan Lau, Edman TK Lam, Ken HL Ng, Rickjason CW Chan |
| 104 |
[GO] |
2022―Apr―05 |
Reviewing findings on the polypeptide sequence of the SARS-CoV-2 S-protein to discuss the origins of the virus |
Alberto Maria Cattaneo |
| 105 |
[GO] |
2022―Apr―04 |
In silico discovery of non-psychoactive scaffolds in Cannabis halting SARS-CoV-2 host entry and replication machinery |
Amira R Khattab, Mohamed Teleb |
| 106 |
[GO] |
2022―Mar―21 |
Can anti-parasitic drugs help control COVID-19? |
Yasin Panahi, Masoomeh Dadkhah, Sahand Talei, Zahra Gharari, Vahid Asghariazar, Arash Abdolmaleki, Somayeh Matin, Soheila Molaei |
| 107 |
[GO] |
2022―Mar―17 |
A community call to action: mitigating COVID pandemic’s impact on mental health |
Wahid Ullah, Muhammad Ilyas, Mukhtar Alam, Jong Bhak, Peter J Tonellato |
| 108 |
[GO] |
2022―Mar―08 |
Massive third wave of COVID-19 outbreak in Bangladesh: a co-epidemic of dengue might worsen the situation |
Popy Devnath, Md. Jamal Hossain, Talha Bin Emran, Saikat Mitra |
| 109 |
[GO] |
2022―Mar―01 |
Airborne transmission of SARS-CoV-2 disease (COVID-19) |
Mohammad K Parvez, Shama Parveen |
| 110 |
[GO] |
2022―Feb―21 |
A nomogram predicting the severity of COVID-19 based on initial clinical and radiologic characteristics |
Hanfei Zhang, Feiyang Zhong, Binchen Wang, Meiyan Liao |
| 111 |
[GO] |
2022―Feb―11 |
Cervical and preauricular lymphadenopathies as atypical manifestations in the setting of COVID-19: a case report |
Alireza Ala, Solomon Habtemariam, Samad Shams Vahdati, Aysa Rezabakhsh |
| 112 |
[GO] |
2022―Feb―10 |
Research progresses in vertical transmission of SARS-CoV-2 among infants born to mothers with COVID-19 |
Zhoujie Peng, Jing Zhang, Yuan Shi, Ming Yi |
| 113 |
[GO] |
2022―Feb―10 |
Antineutrophil cytoplasmic antibody positivity and clinical implications in COVID-19 |
Serdar Can Güven, Hakan Apaydın, Bahar Özdemir, Berkan Armağan, İhsan Ateş, Abdulsamet Erden, Orhan Küçükşahin, Ahmet Omma |
| 114 |
[GO] |
2022―Feb―10 |
Computed tomography evaluation of pancreatic steatosis: correlation with COVID-19 prognosis |
Serkan Guneyli, Hakan Dogan, Omer Tarik Esengur, Hur Hassoy |
| 115 |
[GO] |
2022―Jan―31 |
Efficacy of lopinavir-ritonavir combination therapy for the treatment of hospitalized COVID-19 patients: a meta-analysis |
Jiawen Deng, Fangwen Zhou, Wenteng Hou, Kiyan Heybati, Saif Ali, Oswin Chang, Zachary Silver, Thanansayan Dhivagaran, Harikrishnaa Ba Ramaraju, Chi Yi Wong, Qi Kang Zuo, Elizabeth Lapshina, Madeline Mellett |
| 116 |
[GO] |
2022―Jan―12 |
Rethinking methods used to evaluate effectiveness of therapeutics for COVID-19 and other viral respiratory illnesses |
Jean-François Rossignol |
| 117 |
[GO] |
2022―Jan―12 |
Anterior ischemic optic neuropathy as a rare manifestation of COVID-19: a case report |
Khodayar Golabchi, Alireza Rezaee, Davood Aghadoost, Maryam Hashemipour |
| 118 |
[GO] |
2021―Dec―15 |
A systematic review and meta-analysis of the sensitivity of antibody tests for the laboratory confirmation of COVID-19 |
Nigel A Makoah, Thomas Tipih, Matefo M Litabe, Mareza Brink, Joseph B Sempa, Dominique Goedhals, Felicity J Burt |
| 119 |
[GO] |
2021―Dec―15 |
Identifying asymptomatic cases during the mass COVID-19 vaccination campaign: insights and implications for policy makers |
Francesco Chirico, Gabriella Nucera, Olayinka Ilesanmi, Aanuoluwapo Afolabi, Michal Pruc, Lukasz Szarpak |
| 120 |
[GO] |
2021―Dec―15 |
Performance of six SARS-CoV-2 RNA detection systems in symptomatic and asymptomatic pediatric and maternal patients |
Cameron A Brown, Megan H Amerson-Brown, Aliza Rahman, Charity R Webb, Ila R Singh, James J Dunn |
| 121 |
[GO] |
2021―Dec―06 |
Myocarditis and COVID-19 mRNA vaccines: a mechanistic hypothesis involving dsRNA |
Gerard Milano, Jocelyn Gal, Anne Creisson, Emmanuel Chamorey |
| 122 |
[GO] |
2021―Dec―03 |
Efficacy of chloroquine and hydroxychloroquine for the treatment of hospitalized COVID-19 patients: a meta-analysis |
Jiawen Deng, Fangwen Zhou, Kiyan Heybati, Saif Ali, Qi Kang Zuo, Wenteng Hou, Thanansayan Dhivagaran, Harikrishnaa Ba Ramaraju, Oswin Chang, Chi Yi Wong, Zachary Silver |
| 123 |
[GO] |
2021―Nov―26 |
A brief review on DNA vaccines in the era of COVID-19 |
Maryam Shafaati, Massoud Saidijam, Meysam Soleimani, Fereshte Hazrati, Rasoul Mirzaei, Bagher Amirheidari, Hamid Tanzadehpanah, Sajad Karampoor, Sima Kazemi, Bahram Yavari, Hanie Mahaki, Mohsen Safaei, Fatemeh Rahbarizadeh, Pouria Samadi, Yaghoub Ahmadyousefi |
| 124 |
[GO] |
2021―Nov―26 |
Non-SARS, non-MERS human coronavirus infections and risk of Kawasaki disease: a meta-analysis |
Pratap Kumar Patra, Rashmi Ranjan Das, Aaqib Zaffar Banday, Mini Singh, Kapil Goyal, Ankur Kumar Jindal, Surjit Singh |
| 125 |
[GO] |
2021―Nov―26 |
Pediatric multisystem inflammatory syndrome temporally associated with SARS-CoV-2 symptoms in Iran |
Mehran Akbari, Mojtaba Didehdar, Mohsen Nazari, Davood Azadi |
| 126 |
[GO] |
2021―Nov―12 |
Detection and predictors of anti-SARS-CoV-2 antibody levels in COVID-19 patients at 8 months after symptom onset |
Jing Guo, Li Li, Qian Wu, Hongwei Li, Yajie Li, Xinwei Hou, Fangfei Yang, Zhonghua Qin |
| 127 |
[GO] |
2021―Nov―12 |
Temporal variations of country-specific mutational profile of SARS-CoV-2: effect on vaccine efficacy |
Sayantan Laha, Raghunath Chatterjee |
| 128 |
[GO] |
2021―Nov―04 |
The Mu strain: the last but not least circulating ‘variant of interest’ potentially affecting the COVID-19 pandemic |
Farid Rahimi, Negin Kamali, Amin Talebi Bezmin Abadi |
| 129 |
[GO] |
2021―Nov―04 |
In-hospital clinical complications of COVID-19: a brief overview |
Kevin John John, Jemimah Nayar, Ajay Kumar Mishra, Vijairam Selvaraj, Mohammad Saud Khan, Amos Lal |
| 130 |
[GO] |
2021―Nov―04 |
The third booster vaccination dose against COVID-19: indication for circulating SARS-CoV-2 variants |
Farid Rahimi, Amin Talebi Bezmin Abadi |
| 131 |
[GO] |
2021―Nov―04 |
SARS-CoV-2 nomenclature: viruses, variants and vaccines need a standardized naming system |
Tariq Khan, Syed Muhammad Jamal |
| 132 |
[GO] |
2021―Oct―29 |
The international treaty for pandemic preparedness and response: same story, different times? |
Dominique Vervoort, Xiya Ma, Alia Sunderji, Hloni Bookholane |
| 133 |
[GO] |
2021―Oct―19 |
Rare cutaneous manifestation of COVID-19 infection and Pfizer-BioNTech COVID-19 vaccine with a unique pattern similarity |
Anthony Fata, Georges Jabbour, Hampig Kourie, Marianne Zoghbi, Elia Kassouf, Antoine Zoghbi |
| 134 |
[GO] |
2021―Oct―14 |
Detection of SARS-CoV-2 in the sewerage system in Tunisia: a promising tool to confront COVID-19 pandemic |
Habib Jmii, Hakima Gharbi-Khelifi, Raouia Assaoudi, Mahjoub Aouni |
| 135 |
[GO] |
2021―Oct―08 |
Computed tomography-positive, SARS-CoV-2 RNA-negative symptomatic contacts of COVID-19 patients: what are their nature and implications? |
Lei Huang |
| 136 |
[GO] |
2021―Oct―08 |
A case series of pediatric COVID-19 with complicated symptoms in Iran |
Fatemeh Cheraghali, Leila Barati, Dayan Amanian, Lobat Shahkar, Maryam Najafinejad, Hamed Naziri, Somayeh Shahabi, Alijan Tabarraei, Alireza Tahamtan |
| 137 |
[GO] |
2021―Sep―22 |
Association between blood groups and COVID-19 outcome in Iranian patients |
Ali Asghar Ayatollahi, Bahman Aghcheli, Abolfazl Amini, Hasan Nikbakht, Parastoo Ghassemzadehpirsala, Emad Behboudi, Abdolhalim Rajabi, Alireza Tahamtan |
| 138 |
[GO] |
2021―Sep―21 |
High-value laboratory testing for hospitalized COVID-19 patients: a review |
Daniela Cihakova, Michael B Streiff, Steven P Menez, Teresa K Chen, Nisha A Gilotra, Erin D Michos, Kieren A Marr, Andrew H Karaba, Matthew L Robinson, Paul W Blair, Maria V Dioverti, Wendy S Post, Andrea L Cox, Annukka A R Antar |
| 139 |
[GO] |
2021―Sep―10 |
Fast evolution of SARS-CoV-2 driven by deamination systems in hosts |
Yanping Zhang, Wen Jiang, Yan Li, Xiaojie Jin, Xiaoping Yang, Pirun Zhang, Wenqing Jiang, Bin Yin |
| 140 |
[GO] |
2021―Sep―02 |
Serum biochemical parameters as a surrogate marker for chest computed tomography in children with COVID-19 |
Karuna M Das, Rajvir Singh, Sandeep Subramanya, Shreesh Kumar Ojha, Taleb Almansoori, Dilip Gokhale, Jamal Aldeen Alkoteesh |
| 141 |
[GO] |
2021―Sep―02 |
mRNA-based COVID-19 vaccines appear not to increase immune events in cancer patients receiving immune checkpoint inhibitors |
Emre Yekedüz, Rüveyda Ayasun, Elif Berna Köksoy, Güngör Utkan, Yüksel Ürün, Hakan Akbulut |
| 142 |
[GO] |
2021―Aug―09 |
Harnessing immunological targets for COVID-19 immunotherapy |
Abhishesh Kumar Mehata, Matte Kasi Viswanadh, Vishnu Priya, Madaswamy S Muthu |
| 143 |
[GO] |
2021―Jul―29 |
Independent and incremental prognostic value of D-dimer in hospitalized COVID-19 patients |
Gerald Chi, Sahar Memar Montazerin, Jane J Lee |
| 144 |
[GO] |
2021―Jul―20 |
Potential drugs against COVID-19 revealed by gene expression profile, molecular docking and molecular dynamic simulation |
Claudia Cava, Gloria Bertoli, Isabella Castiglioni |
| 145 |
[GO] |
2021―Jul―20 |
An overview of sex hormones in relation to SARS-CoV-2 infection |
Marzieh Saei Ghare Naz, Mojdeh Banaei, Sareh Dashti, Fahimeh Ramezani Tehrani |
| 146 |
[GO] |
2021―Jul―20 |
In silico discovery of SARS-CoV-2 main protease inhibitors from the carboline and quinoline database |
Eldar Muhtar, Mengyang Wang, Haimei Zhu |
| 147 |
[GO] |
2021―Jul―13 |
Reappraisal of trifluperidol against Nsp3 as a potential therapeutic for novel COVID-19: a molecular docking and dynamics study |
Ajita Pandey, Mohit Sharma |
| 148 |
[GO] |
2021―Jul―13 |
Targeting SARS-CoV-2 nonstructural protein 15 endoribonuclease: an in silico perspective |
Shafi Mahmud, Abdo A Elfiky, Al Amin, Sumon Chandro Mohanto, Ekhtiar Rahman, Uzzal Kumar Acharjee, Abu Saleh |
| 149 |
[GO] |
2021―Jul―08 |
Association of anemia and COVID-19 in hospitalized patients |
Chong Chen, Wenhui Zhou, Wenliang Fan, Xianying Ning, Shuai Yang, Ziqiao Lei, Chuansheng Zheng |
| 150 |
[GO] |
2021―Jul―06 |
Association of administration of IFN-α with mortality among patients hospitalized with coronavirus disease 2019 |
Hanqing Liu, Zhouru Ruan, Ziwei Yin, Dan Wu, Hong Zhu |
| 151 |
[GO] |
2021―Jun―30 |
Safety, efficacy and acceptability of SARS-CoV-2 vaccines in patients with cancer |
Roy Chebel, Chris Labaki, Maria Farhat, Joseph Kattan |
| 152 |
[GO] |
2021―Jun―22 |
The COVID-19 pandemic: an increased risk of rheumatoid arthritis |
Archana Tripathy, Nitish Swain, Bhawna Gupta |
| 153 |
[GO] |
2021―Jun―22 |
V483A: an emerging mutation hotspot of SARS-CoV-2 |
Omar Ashwaq, Pratibha Manickavasagam, SK Manirul Haque |
| 154 |
[GO] |
2021―Jun―22 |
Vertical transmission potential of SARS-CoV-2 from infected mother to twin neonates |
Liangyu Peng, Suliman Khan, Ashaq Ali, Saeed Ahmed, Liaqat Ali, Guang Han, Yang Jing |
| 155 |
[GO] |
2021―Jun―01 |
Druggability of cavity pockets within SARS-CoV-2 spike glycoprotein and pharmacophore-based drug discovery |
Alireza Mohebbi, Fatemeh Sana Askari, Ali Salehnia Sammak, Mohsen Ebrahimi, Zahra Najafimemar |
| 156 |
[GO] |
2021―May―24 |
Tocilizumab in the treatment of coronavirus disease 2019 pneumonia: real-world data from a case series |
Ran Cui, Ying Zhu, Yulan Wang, Xiao-Hua Chen, Qiang Li, Sheng-Ming Dai, Qiang Tong |
| 157 |
[GO] |
2021―May―19 |
Natural selection on synonymous mutations in SARS-CoV-2 and the impact on estimating divergence time |
Yuanyuan Yu, Yan Li, Yu Dong, Xuekun Wang, Chunxiao Li, Wenqing Jiang |
| 158 |
[GO] |
2021―May―19 |
SARS-CoV-2 likely targets cellular PDZ proteins: a common tactic of pathogenic viruses |
Andrew P Rice, Jason T Kimata |
| 159 |
[GO] |
2021―May―12 |
Predictive values of biochemical markers as early indicators for severe COVID-19 cases in admission |
Emin Gemcioglu, Mehmet Davutoglu, Ramis Catalbas, Berkan Karabuga, Enes Kaptan, Adalet Aypak, Ayse K Kalem, Mustafa Özdemir, Necati Y Yeşilova, Emra A Kalkan, Musa Civak, Orhan Kücüksahin, Abdulsamet Erden, Ihsan Ates |
| 160 |
[GO] |
2021―Apr―26 |
An analysis of inhibition of the severe acute respiratory syndrome coronavirus 2 RNA-dependent RNA polymerase by zinc ion: an in silico approach |
Sina Zoghi, Hossein Jafari Khamirani, Seyed Alireza Dastgheib, Mehdi Dianatpour, Alireza Ghaffarieh |
| 161 |
[GO] |
2021―Apr―22 |
HIV and COVID-19 pandemic collision: turning challenges into opportunity |
Stefano Rusconi, Laura Pezzati, Tiziana Formenti, Andrea Giacomelli |
| 162 |
[GO] |
2021―Apr―21 |
Investigation of the relationship between inherited thrombophilia and novel coronavirus pneumonia |
Aslihan Kiraz, Seda Guzeldag, Esma Eren, Musa Goksu, Arslan Bayram |
| 163 |
[GO] |
2021―Apr―14 |
The initial infectious dose of SARS-CoV-2 and the severity of the disease: possible impact on the incubation period |
Hamid Tayebi Khosroshahi, Alireza Mardomi |
| 164 |
[GO] |
2021―Apr―07 |
Abnormal myocardial enzymes are important indicators of poor prognosis in COVID-19 patients |
Jingping Cheng, Wanxin Liu, Siyang Chen, Xiafen Hu, Xiaochen Xiang, Zhongliang Cheng, Shaoqian Cai, Kaiwen Guo, Qiang Wang, Xiaoliu Liu, Qingming Wu |
| 165 |
[GO] |
2021―Apr―06 |
Xerostomia (dry mouth) in patients with COVID-19: a case series |
Yaser Fathi, Elaheh Ghasemzadeh Hoseini, Fatemeh Atoof, Reza Mottaghi |
| 166 |
[GO] |
2021―Mar―25 |
Exploring the binding efficacy of ivermectin against the key proteins of SARS-CoV-2 pathogenesis: an in silico approach |
Abhigyan Choudhury, Nabarun C Das, Ritwik Patra, Manojit Bhattacharya, Pratik Ghosh, Bidhan C Patra, Suprabhat Mukherjee |
| 167 |
[GO] |
2021―Mar―24 |
The role of miRNAs in COVID-19 disease |
Mona Fani, Milad Zandi, Saeedeh Ebrahimi, Saber Soltani, Samaneh Abbasi |
| 168 |
[GO] |
2021―Mar―09 |
Erythema multiform-like lesions in a patient infected with SARS-CoV-2: a case report |
Yaser Fathi, Elaheh Ghasemzadeh Hoseini, Reza Mottaghi |
| 169 |
[GO] |
2021―Mar―08 |
Comparative sequence analysis of SARS-CoV-2 suggests its high transmissibility and pathogenicity |
Kartika Padhan, Mohammad K Parvez, Mohammed S Al-Dosari |
| 170 |
[GO] |
2021―Mar―02 |
Computational guided approach for drug repurposing against SARS-CoV-2 |
Jigisha Anand, Tanmay Ghildiyal, Aakanksha Madhwal, Rishabh Bhatt, Devvret Verma, Nishant Rai |
| 171 |
[GO] |
2021―Feb―24 |
Epidemiologic features and clinical course of COVID-19: a retrospective analysis of 19 patients in Germany |
Sara Elgamasy, Eman Elsayed Sakr, Mohamed Gomaa Kamel, Sherief Ghozy, Ghadeer Gamal Elsayed, Mostafa Mahmoud Fahmy, Ahmed Ghazy, Mohamed Maged Nagaty Ibrahim, Mostafa Ebraheem Morra |
| 172 |
[GO] |
2021―Feb―22 |
Scouting the receptor-binding domain of SARS coronavirus 2: a comprehensive immunoinformatics inquisition |
Zaira Rehman, Ammad Fahim, Muhammad Faraz Bhatti |
| 173 |
[GO] |
2021―Feb―09 |
The long-quarantined case of COVID-19 with prolonged viral shedding and intermittent fever for more than 70 days |
Eijiro Yamada, Emi Ishida, Yasuyo Nakajima, Kazuhiko Horiguchi, Shunichi Matsumoto, Shuichi Okada, Wataru Kamitani, Masanobu Yamada |
| 174 |
[GO] |
2021―Feb―04 |
What is the intermediate host species of SARS-CoV-2? |
Thomas Friend, Justin Stebbing |
| 175 |
[GO] |
2021―Feb―03 |
SARS-CoV-2 direct real-time polymerase chain reaction testing in laboratories with shortage challenges |
Taghreed Alaifan, Asmaa Altamimi, Dalia Obeid, Turki Alshehri, Shaihana Almatrrouk, Ahmed Albarrag |
| 176 |
[GO] |
2021―Jan―28 |
Asymptomatic carriers of coronavirus disease 2019 among healthcare workers in Isfahan, Iran |
Hamed Fakhim, Elahe Nasri, Shima Aboutalebian, Sahar Gholipour, Mahnaz Nikaeen, Afsane Vaezi, Somayeh Mousavi, Sama Faramarzi, Armin Farhang, Shaghayegh Haghjooy Javanmard, Mehrdad Salahi, Ali Darakhshandeh, Kazem Ahmadikia, Hossein Mirhendi |
| 177 |
[GO] |
2021―Jan―26 |
Severe acute respiratory syndrome coronavirus 2 viral load in respiratory and feces specimens of children with coronavirus disease 2019 |
Xiang Ma, Liang Su, Lu Cheng, Zhaohua Zhang, Jing Sun, Miao Liu, Jing Wang, Xuemei Jiang, Yun Zhang, Yuling Han, Zhongfa Zhang, Zhongtao Gai |
| 178 |
[GO] |
2021―Jan―25 |
Clinical characteristics of outpatients and inpatients with COVID-19 in Bushehr: a report from the south of Iran |
Mohsen Keshavarz, Ahmad Tavakoli, Sareh Zanganeh, Mohammad Javad Mousavi, Katayoun Vahdat, Mehdi Mahmudpour, Iraj Nabipour, Amirhossein Darabi, Saeid Keshmiri |
| 179 |
[GO] |
2021―Jan―13 |
Mechanisms of infection by SARS-CoV-2, inflammation and potential links with the microbiome |
María Magdalena Aguirre García, Javier Mancilla-Galindo, Mercedes Paredes-Paredes, Álvaro Zamudio Tiburcio, Nydia Ávila-Vanzzini |
| 180 |
[GO] |
2021―Jan―07 |
A new perspective of the chemistry and kinetics of inactivation of COVID -19 coronavirus aerosols |
Michael L Hitchman |
| 181 |
[GO] |
2020―Dec―24 |
Relationship between IL-6 and COVID-19: to be considered during treatment |
Hafize Seda Vatansever, Eda Becer |
| 182 |
[GO] |
2020―Dec―16 |
Pandemic response management framework based on efficiency of COVID-19 control and treatment |
Mustapha D Ibrahim, Fatima AS Binofai, Reem MM Alshamsi |
| 183 |
[GO] |
2020―Dec―15 |
Can natural detergent properties of bile acids be used beneficially in tackling coronavirus disease-19? |
Yashwant Kumar, Reena Yadav, Alka Bhatia |
| 184 |
[GO] |
2020―Nov―30 |
Phylogenomics and phylodynamics of SARS-CoV-2 genomes retrieved from India |
Sameera Farah, Ashwin Atkulwar, Manas Ranjan Praharaj, Raja Khan, Ravikumar Gandham, Mumtaz Baig |
| 185 |
[GO] |
2020―Nov―26 |
The role of artificial intelligence in tackling COVID-19 |
Neelima Arora, Amit K Banerjee, Mangamoori L Narasu |
| 186 |
[GO] |
2020―Nov―26 |
Phylogenetic and whole genome analysis of first seven SARS-CoV-2 isolates in Bangladesh |
Nadim Sharif, Shuvra K Dey |
| 187 |
[GO] |
2020―Nov―04 |
LIF and the lung’s stem cell niche: is failure to use LIF to protect against COVID-19 a grave omission in managing the pandemic? |
Su M Metcalfe |
| 188 |
[GO] |
2020―Oct―28 |
A multiple-center clinical evaluation of a new real-time reverse transcriptase PCR diagnostic kit for SARS-CoV-2 |
Jing-Jing Guo, Yan-Hua Yu, Xue-Ying Ma, Ya-Nan Liu, Qian Fang, Pei Qu, Jie Guo, Jin-Li Lou, Ya-Jie Wang |
| 189 |
[GO] |
2020―Oct―27 |
Perversely expressed long noncoding RNAs can alter host response and viral proliferation in SARS-CoV-2 infection |
Rafeed Rahman Turjya, Md. Abdullah-Al-Kamran Khan, Abul Bashar Mir Md. Khademul Islam |
| 190 |
[GO] |
2020―Oct―22 |
Clinical characteristics and outcomes of discharged COVID-19 patients with reoccurrence of SARS-CoV-2 RNA |
Jing Wu, Xiao-ying Xia, He-lei Liu, Hong Xia, Wen-xiang Huang, Bei Jia, Feng-ying Peng |
| 191 |
[GO] |
2020―Oct―14 |
A comprehensive review about SARS-CoV-2 |
SK Manirul Haque, Omar Ashwaq, Abdulla Sarief, Abdul Kalam Azad John Mohamed |
| 192 |
[GO] |
2020―Oct―13 |
Implications of current and future approaches to coronavirus disease 2019 testing |
Rasheid Smith, Sean M Geary, Aliasger K Salem |
| 193 |
[GO] |
2020―Oct―08 |
The potential of lactoferrin, ovotransferrin and lysozyme as antiviral and immune-modulating agents in COVID-19 |
Jaclyn Kelly Mann, Thumbi Ndung'u |
| 194 |
[GO] |
2020―Oct―08 |
In silico analysis of protein/peptide-based inhalers against SARS-CoV-2 |
Saad Salman, Fahad Hassan Shah, Maham Chaudhry, Muniba Tariq, Muhammad Yasir Akbar, Muhammad Adnan |
| 195 |
[GO] |
2020―Aug―26 |
Investigation of compatibility of severe acute respiratory syndrome coronavirus 2 reverse transcriptase-PCR kits containing different gene targets during coronavirus disease 2019 pandemic |
Figen Sarıgül, Osman Doluca, Sıla Akhan, Murat Sayan |
| 196 |
[GO] |
2020―Aug―26 |
Genetic and pathogenic characterization of SARS-CoV-2: a review |
Afsane Bahrami, Gordon A Ferns |
| 197 |
[GO] |
2020―Aug―18 |
A flow virometry process proposed for detection of SARS-CoV-2 and large-scale screening of COVID-19 cases |
Niraja Soni, Puja Pai, Gurumurthy Raja Krishna Kumar, Venkatesh Prasad, Santanu Dasgupta, Bhaskar Bhadra |
| 198 |
[GO] |
2020―Aug―17 |
Susceptibility of the Iranian population to severe acute respiratory syndrome coronavirus 2 infection based on variants of angiotensin I converting enzyme 2 |
Alireza Mohebbi, Fatemeh Sana Askari, Mohsen Ebrahimi, Mana Zakeri, Mohammad Yasaghi, Hanieh Bagheri, Naeme Javid |
| 199 |
[GO] |
2020―Aug―12 |
Thoughts on detecting tissue distribution of potential COVID-19 receptors |
Hongtao Tang, Xiaosheng Lu, Shuyan Qie, Jianing Xi |
| 200 |
[GO] |
2020―Jul―29 |
In silico identification of conserved cis-acting RNA elements in the SARS-CoV-2 genome |
Bader Y Alhatlani |
| 201 |
[GO] |
2020―Jul―27 |
COVID-19: studying the global pandemic - foreword |
Stefano Rusconi, Frederick G Hayden |
| 202 |
[GO] |
2020―Jul―27 |
Therapeutic and vaccine strategies against SARS-CoV-2: past, present and future |
Mubasher Rehman, Isfahan Tauseef, Bibi Aalia, Sajid Hussain Shah, Muhammad Junaid, Kashif Syed Haleem |
| 203 |
[GO] |
2020―Jun―26 |
COVID-19 in homeless populations: unique challenges and opportunities |
Brian Conway, David Truong, Kelli Wuerth |
| 204 |
[GO] |
2020―Jun―12 |
COVID-19 and coronaviral hepatitis: evidence of collateral damage |
Mohammad K Parvez |
| 205 |
[GO] |
2020―Jun―12 |
Transmission and clinical characteristics of asymptomatic patients with SARS-CoV-2 infection |
Jie Tan, Shousheng Liu, Likun Zhuang, Lizhen Chen, Mengzhen Dong, Jie Zhang, Yongning Xin |
| 206 |
[GO] |
2020―May―29 |
A suspected case of COVID-19 turned into a confirmed case: a case report from Iran |
Di Yang, Kai Wei, Xuesong Gao, Yijin Zhang, Ping Gao, Hongjie Li, Xiaomin Liu, Zheng Yuan, Te Xiao, Wenshan Zhao, Xuefei Duan |
| 207 |
[GO] |
2020―May―26 |
Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) infection: let the virus be its own demise |
John Nemunaitis, Laura Stanbery, Neil Senzer |
| 208 |
[GO] |
2020―May―20 |
Comparison of the COVID-2019 (SARS-CoV-2) pathogenesis with SARS-CoV and MERS-CoV infections |
Mona Fani, Ali Teimoori, Shokouh Ghafari |
| 209 |
[GO] |
2020―May―12 |
Prediction and analysis of key protein structures of 2019-nCoV |
Qihao Li, Wen Peng, Yu Ou |
| 210 |
[GO] |
2020―Apr―24 |
The divergence between SARS-CoV-2 and RaTG13 might be overestimated due to the extensive RNA modification |
Yue Li, Xinai Yang, Na Wang, Haiyan Wang, Bin Yin, Xiaoping Yang, Wenqing Jiang |
| 211 |
[GO] |
2020―Apr―17 |
Pros and cons of the application of evolutionary theories to the evolution of SARS-CoV-2 |
Yue Li, Xinai Yang, Na Wang, Haiyan Wang, Bin Yin, Xiaoping Yang, Wenqing Jiang |
